pf-06863135,daratumumab,Elranatamab
pfizer,janssen
['magnetismm-5', 'multiplemyeloma', '1921', 'pfizer']
at #ash22, see results from the safety lead-in cohort for the phase 3 magnetismm-5 study evaluating the combination regimen of a bcma-cd3 bispecific antibody (bsab) and an anti-cd38 mab for patients with relapsed/refractory #multiplemyeloma 1921 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ